Renalytix AI plc Made Headway
Thu, Feb 08, 2024 at 07:14 PM
Renalytix AI plc (RNLX:NASDAQ) rocketted at $0.54, representing a gain of 96.9%. On Thu, Feb 08, 2024, RNLX:NASDAQ touched a New 2-Week High of $0.54. From Thu, Jan 25, 2024, the stock recorded 40.00% Up Days and 18.18% Green Days
About Renalytix AI plc (RNLX:NASDAQ)
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.
Top 10 Gainers:
- Syra Health Corp. (SYRA:NASDAQ), 321.74%
- Hitek Global Inc. (HKIT:NASDAQ), 218.42%
- NanoString Technologies, Inc. (NSTG:NASDAQ), 118.42%
- Renalytix AI plc (RNLX:NASDAQ), 96.87%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 83.4%
- MicroAlgo Inc. (MLGO:NASDAQ), 82.46%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 59.44%
- MoneyHero Limited (MNY:NASDAQ), 59.09%
- Foghorn Therapeutics Inc. (FHTX:NASDAQ), 55.45%
- Arm Holdings plc (ARM:NASDAQ), 47.89%